Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Florida
| Provider | Medicare | Services |
|---|---|---|
| Hematopathology Associates Llc | $764.40 | 1.4K |
| Biogroup Laboratory Corp | $764.40 | 936 |
| Ideal Diagnostic | $764.40 | 523 |
| Genetics Institute Of America... | $764.40 | 438 |
| Apprise Diagnostics Llc | $764.40 | 200 |
| Precheck Health Services Inc | $764.40 | 98 |
| Dynix Diagnostix | $764.40 | 88 |
| Up Services Inc | $752.97 | 72 |
| Primary Diagnostics Laboratory Pllc | $764.40 | 72 |
| Pro Diametrics Corp | $764.40 | 49 |
| Clear Choice Diagnostics Inc | $764.40 | 37 |
| Galatea Bio, Inc. | $764.40 | 35 |
| Prince Laboratories Limited... | $764.40 | 34 |
| Molecular Clinical Laboratory, Inc | $764.40 | 34 |
| Reliable Results Labs Inc | $764.40 | 16 |
Florida Pricing in Context
In Florida, CPT code 81201 (Gene Analysis (adenomatous Polyposis Coli), Full Gene Sequence) carries an average Medicare payment of $764.17 — 0% above the national benchmark of $764.07. 20 providers across the state submitted claims for this procedure in 2023, performing 4.0K total services. Individual payments in FL ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Florida is $914.68, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Florida sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Genetic/Molecular Test procedures, the estimated commercial insurance price in Florida lands near $1,795.79, with self-pay cash prices typically around $824.66. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Gene Analysis (adenomatous Polyposis Coli), Full Gene Sequence cost in Florida?
The average Medicare payment for Gene Analysis (adenomatous Polyposis Coli), Full Gene Sequence in Florida is $764.17, which is 0% above the national average of $764.07. Providers in FL typically bill $914.68 for this procedure.
What does Gene Analysis (adenomatous Polyposis Coli), Full Gene Sequence cost with insurance in Florida?
With commercial insurance in Florida, Gene Analysis (adenomatous Polyposis Coli), Full Gene Sequence costs an estimated $1,795.79. Without insurance, the estimated cash price is $824.66. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Gene Analysis (adenomatous Polyposis Coli), Full Gene Sequence in Florida?
20 providers in Florida billed Medicare for Gene Analysis (adenomatous Polyposis Coli), Full Gene Sequence in 2023, performing 4.0K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Gene Analysis (adenomatous Polyposis Coli), Full Gene Sequence cheaper in Florida than the national average?
No — Gene Analysis (adenomatous Polyposis Coli), Full Gene Sequence costs 0% above the national average in Florida. The state average Medicare payment is $764.17 compared to $764.07 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.